Acute graft-versus-host disease (aGVHD) is one of the most serious complications after allogeneic hematopoietic stem cell ...
Acute graft-versus-host disease (aGVHD) is a life-threatening complication after allogeneic hematopoietic stem cell ...
In July 2025, a class 2 resubmission of tab-cel’s BLA was initiated by Atara Biotherapeutics, developer and sponsor of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback